You searched for "legislation"
What's trending Apr/May 2022
A round-up of the eye-related hot topics that have been trending over the last few weeks. #ArgusI #ArgusII #bioniceye #retinitispigmentosa #SecondSight Remember Argus I & Argus II? Its star burned bright, touted as the future of treatment for retinitis pigmentosa....What's trending Oct/Nov 2020
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #oldEnglish #herbalremedies Researchers from the University of Warwick, investigating natural remedies to treat bacterial infections, have discovered a potential new treatment....10 daily habits damaging your eyesight and changes you can make to remedy against them
Following World Glaucoma Day on 12 March this year, it is vital that the longevity of our vision is always a priority. However, many of our daily habits contribute to the onset of glaucoma and vision loss.
Atlas Of Orbital Imaging
It was an absolute pleasure to review this beautifully written textbook. Authorship is from a diverse, international group of experienced and respected oculoplastic surgeons with an interest in orbital disease. A significant contribution to most of these chapters has been...Oct/Nov 2018 Quiz
History A 37-year-old male was referred from the Emergency Eye Clinic with a swollen right upper eyelid. Symptom relieved with nonsteroidal anti-inflammatory drugs (NSAIDs). The initial clinical diagnosis was dacryoadenitis. The patient presented again six weeks later with 3mm proptosis,...Aug/Sep 2014 Quiz 1
History A 50-year-old female with a history of smoking, weight loss and cough presents to the ophthalmology clinic with a distorted pupil. Examination reveals a mass on the surface and within the iris (see Figure 1). The ophthalmologists decide to...From the Editors: Back in the habit!
Recently I spoke at an ophthalmic conference in London. It was amazing to be back amongst friends and colleagues in person again, to learn and share with one another. I also took the opportunity to stay on for a few...
Post hoc analysis of the CANTREAT randomised trial
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...
Intravitreal afibercept and ranibizumab for PCV
This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...
